Home Healthcare Pharmaceuticals Pulmonary Arterial Hypertension Market

Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class (Prostacyclin and Prostacyclin Analogs, SGC Stimulators, ERA, PDE-5) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR4781DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Pulmonary Arterial Hypertension Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Prostacyclin and Prostacyclin Analogs
    2. SGC Stimulators
    3. ERA
    4. PDE-5
  2. Regional Pulmonary Arterial Hypertension Market
    1. North America
      1. North America Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
      2. U.S. Pulmonary Arterial Hypertension Market
        1. U.S. Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      3. Canada Pulmonary Arterial Hypertension Market
        1. Canada Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
    2. Europe
      1. Europe Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
      2. U.K. Pulmonary Arterial Hypertension Market
        1. U.K. Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      3. Germany Pulmonary Arterial Hypertension Market
        1. Germany Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      4. France Pulmonary Arterial Hypertension Market
        1. France Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      5. Spain Pulmonary Arterial Hypertension Market
        1. Spain Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      6. Italy Pulmonary Arterial Hypertension Market
        1. Italy Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      7. Russia Pulmonary Arterial Hypertension Market
        1. Russia Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      8. Nordic Pulmonary Arterial Hypertension Market
        1. Nordic Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      9. Benelux Pulmonary Arterial Hypertension Market
        1. Benelux Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      10. Rest of Europe Pulmonary Arterial Hypertension Market
        1. Rest of Europe Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
    3. APAC
      1. APAC Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
      2. China Pulmonary Arterial Hypertension Market
        1. China Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      3. Korea Pulmonary Arterial Hypertension Market
        1. Korea Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      4. Japan Pulmonary Arterial Hypertension Market
        1. Japan Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      5. India Pulmonary Arterial Hypertension Market
        1. India Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      6. Australia Pulmonary Arterial Hypertension Market
        1. Australia Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      7. Singapore Pulmonary Arterial Hypertension Market
        1. Singapore Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      8. Taiwan Pulmonary Arterial Hypertension Market
        1. Taiwan Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      9. South East Asia Pulmonary Arterial Hypertension Market
        1. South East Asia Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      10. Rest of Asia-Pacific Pulmonary Arterial Hypertension Market
        1. Rest of Asia-Pacific Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
    4. Middle East and Africa
      1. Middle East and Africa Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
      2. UAE Pulmonary Arterial Hypertension Market
        1. UAE Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      3. Turkey Pulmonary Arterial Hypertension Market
        1. Turkey Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      4. Saudi Arabia Pulmonary Arterial Hypertension Market
        1. Saudi Arabia Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      5. South Africa Pulmonary Arterial Hypertension Market
        1. South Africa Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      6. Egypt Pulmonary Arterial Hypertension Market
        1. Egypt Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      7. Nigeria Pulmonary Arterial Hypertension Market
        1. Nigeria Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      8. Rest of MEA Pulmonary Arterial Hypertension Market
        1. Rest of MEA Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
    5. LATAM
      1. LATAM Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
      2. Brazil Pulmonary Arterial Hypertension Market
        1. Brazil Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      3. Mexico Pulmonary Arterial Hypertension Market
        1. Mexico Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      4. Argentina Pulmonary Arterial Hypertension Market
        1. Argentina Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      5. Chile Pulmonary Arterial Hypertension Market
        1. Chile Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      6. Colombia Pulmonary Arterial Hypertension Market
        1. Colombia Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
      7. Rest of LATAM Pulmonary Arterial Hypertension Market
        1. Rest of LATAM Pulmonary Arterial Hypertension Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Prostacyclin and Prostacyclin Analogs
          2. SGC Stimulators
          3. ERA
          4. PDE-5
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.